Literature DB >> 3756079

Plasma lipids and prolactin in patients with breast cancer.

I A Bani, C M Williams, P S Boulter, J W Dickerson.   

Abstract

In a comparative study of pre- and postmenopausal women with benign and malignant breast disease, a number of differences were observed in circulating plasma prolactin and lipid concentrations. Plasma lipids, phospholipids, triglycerides, cholesterol and free fatty acids were all higher in blood obtained from breast cancer patients prior to surgery. HDL-Cholesterol levels were significantly lower in these patients. These differences remained when the patient groups were sub-divided according to menopausal status. Plasma prolactin concentrations were also found to be higher in cancer compared with non-cancer patients, this effect being more marked in premenopausal than in postmenopausal patients. Premenopausal patients with invasive or poorly differentiated disease had significantly higher prolactin levels than those with non-invasive disease. No correlations were found between plasma prolactin and any of the lipid fractions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756079      PMCID: PMC2001617          DOI: 10.1038/bjc.1986.195

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  47 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  THE EFFECT OF GROWTH HORMONE AND PROLACTIN PREPARATIONS ON THE INTERMEDIARY METABOLISM OF RAT ADIPOSE TISSUE.

Authors:  M A HAMID; K A RUBINSTEIN; K A FERGUSON; J C BECK
Journal:  Biochim Biophys Acta       Date:  1965-04-12

3.  An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol.

Authors:  J K Allen; W J Hensley; A V Nicholls; J B Whitfield
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

4.  Intermediary metabolism in the liver and adipose tissue of rats with hormone-secreting pituitary tumors.

Authors:  R M MacLeod; M B Bass; S C Huang; M C Smith
Journal:  Endocrinology       Date:  1968-02       Impact factor: 4.736

5.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

6.  Relation of prolactin and estrogen to mammary tumorigenesis in the rat.

Authors:  J Meites
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

7.  Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice.

Authors:  R Yanai; H Nagasawa
Journal:  Experientia       Date:  1971-08

8.  An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.

Authors:  H G Kwa; D Y Wang
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

9.  Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.

Authors:  A Tarquini; L di Martino; A Malloci; H G Kwa; A A van der Gugten; R D Bulbrook; D Y Wang
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

10.  Circulating levels of prolactin in human breast cancer.

Authors:  N A Sheth; K J Ranadive; J N Suraiya; A R Sheth
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

View more
  18 in total

1.  Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.

Authors:  Chang Hyun Byon; Robert W Hardy; Changchun Ren; Selvarangan Ponnazhagan; Danny R Welch; Jay M McDonald; Yabing Chen
Journal:  Lab Invest       Date:  2009-09-14       Impact factor: 5.662

2.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

Review 3.  Proteinases and myocardial extracellular matrix turnover.

Authors:  S C Tyagi
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

4.  Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan.

Authors:  Padmanabh Inamdar; Garima Mehta
Journal:  Indian J Surg Oncol       Date:  2011-05-06

5.  Serum lipids and apolipoproteins in women with breast masses.

Authors:  D M Lane; K K Boatman; W J McConathy
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 6.  Cholesterol transport and regulation in the mammary gland.

Authors:  Edgar C Ontsouka; Christiane Albrecht
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-02-09       Impact factor: 2.673

7.  Alterations of serum cholesterol and serum lipoprotein in breast cancer of women.

Authors:  Kiran Hasija; Hardeep K Bagga
Journal:  Indian J Clin Biochem       Date:  2005-01

8.  Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women.

Authors:  M Gaard; S Tretli; P Urdal
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

9.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

10.  Plasma lipids in premenopausal women with mammographic dysplasia.

Authors:  N F Boyd; V McGuire; E Fishell; V Kuriov; G Lockwood; D Tritchler
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.